TNF and Hand-foot syndrome: A recent study by Hiromoto et al [4] has tested this theory in particular as its primary outcome on capecitabine-induced HFS in mice and reported a significant reduction in the severity of the HFS (p < 0.05), with it possibly being due to the reduction in the tumour necrosis factor (TNF)-α in the mice limbs (p < 0.01).